BioInquire Releases Proteoiq Version 1.2: Easy Identification of Post-Translationally Modified Proteins
BioInquire releases a new version of the innovative software ProteoIQ with enhanced functionality for analyzing data from proteome wide studies. New enhancements make it easier to identify modified proteins.
Athens, GA, February 03, 2009 --(PR.com)-- BioInquire, LLC today announced the release of ProteoIQ, version 1.2, an innovative and time-saving bioinformatics tool for the analysis of proteomic data. The newest version of ProteoIQ provides researchers with automated methodology for identifying proteins that possess post-translational modifications in a manner that was not previously possible.
New functionality included in ProteoIQ v. 1.2 is specifically designed for researchers using proteomic strategies that involve separations at the protein level followed by digestion and separation at the peptide level, such as Gel-C-MS/MS.
“Current proteomic software was designed for analyzing 2D-gel or MudPIT data, and is not optimal for Gel-C proteomic workflows,” said James Atwood III, Chief Operating Officer and co-founder of BioInquire.
“Comparing the experimental and theoretical molecular weights for the intact proteins identified in a Gel-C experiment enables my lab to quickly identify glycosylated proteins, as these appear at a higher molecular weight than the one calculated solely from the protein’s amino acid sequence,” said Ron Orlando, University of Georgia biochemist , who uses mass spectrometry for the analysis and characterization of proteins and glycoproteins. “ProteoIQ v. 1.2 quickly identifies truncated and degraded proteins as their experimental masses are below the calculated values. To the best of my knowledge, the information gained by the protein separation is lost in other commercial software packages.”
“Our aim with ProteoIQ was to provide a bioinformatics tool that enables researchers to quickly identify meaningful results from mounds of proteomic data. ProteoIQ v. 1.2 is an extension of this philosophy and brings a new dimension to proteomic data analysis,” said D. Brent Weatherly, Chief Executive Officer and co-founder of BioInquire.
ProteoIQ v. 1.2, is particularly well-suited for comparative proteomic analyses, where spectral counting-based quantification is combined with data mining functions to enable researchers to find differences between multiple proteomic data sets. The software generates statistically validated protein sets, which can then be compared. For example, proteins that are different across multiple samples can be easily identified using the difference function. Taking the intersection of two proteomes allows the researcher to obtain expression levels of those proteins in common.
ProteoIQ v.1.2 will be unveiled at the 2009 International Symposium by the Association of Biomolecular Resource Facilities (ABRF), February 7 - 10, 2009 in Memphis, TN, and is available at www.bioinquire.com for scientists not attending this conference. Current ProteoIQ users can upgrade their current software to v1.2, free of charge, at the same website.
About BioInquire:
BioInquire, LLC is a privately-held bioinformatics software company engaged in the development and commercialization of software solutions for mining the products of mass spectrometric analyses, in particular for mining data from proteome wide experiments. BioInquire has received funding from the National Institutes of Health and private sources, including the Georgia Research Alliance. BioInquire is located at the Georgia BioBusiness Center in Athens, GA. For more information, or to download a trial version of ProteoIQ, please visit www.bioinquire.com.
Contact: James A. Atwood
Chief Operating Officer
BioInquire
Phone: 706/583-4000 or 888/291-2246
jatwood@bioinquire.com
###
New functionality included in ProteoIQ v. 1.2 is specifically designed for researchers using proteomic strategies that involve separations at the protein level followed by digestion and separation at the peptide level, such as Gel-C-MS/MS.
“Current proteomic software was designed for analyzing 2D-gel or MudPIT data, and is not optimal for Gel-C proteomic workflows,” said James Atwood III, Chief Operating Officer and co-founder of BioInquire.
“Comparing the experimental and theoretical molecular weights for the intact proteins identified in a Gel-C experiment enables my lab to quickly identify glycosylated proteins, as these appear at a higher molecular weight than the one calculated solely from the protein’s amino acid sequence,” said Ron Orlando, University of Georgia biochemist , who uses mass spectrometry for the analysis and characterization of proteins and glycoproteins. “ProteoIQ v. 1.2 quickly identifies truncated and degraded proteins as their experimental masses are below the calculated values. To the best of my knowledge, the information gained by the protein separation is lost in other commercial software packages.”
“Our aim with ProteoIQ was to provide a bioinformatics tool that enables researchers to quickly identify meaningful results from mounds of proteomic data. ProteoIQ v. 1.2 is an extension of this philosophy and brings a new dimension to proteomic data analysis,” said D. Brent Weatherly, Chief Executive Officer and co-founder of BioInquire.
ProteoIQ v. 1.2, is particularly well-suited for comparative proteomic analyses, where spectral counting-based quantification is combined with data mining functions to enable researchers to find differences between multiple proteomic data sets. The software generates statistically validated protein sets, which can then be compared. For example, proteins that are different across multiple samples can be easily identified using the difference function. Taking the intersection of two proteomes allows the researcher to obtain expression levels of those proteins in common.
ProteoIQ v.1.2 will be unveiled at the 2009 International Symposium by the Association of Biomolecular Resource Facilities (ABRF), February 7 - 10, 2009 in Memphis, TN, and is available at www.bioinquire.com for scientists not attending this conference. Current ProteoIQ users can upgrade their current software to v1.2, free of charge, at the same website.
About BioInquire:
BioInquire, LLC is a privately-held bioinformatics software company engaged in the development and commercialization of software solutions for mining the products of mass spectrometric analyses, in particular for mining data from proteome wide experiments. BioInquire has received funding from the National Institutes of Health and private sources, including the Georgia Research Alliance. BioInquire is located at the Georgia BioBusiness Center in Athens, GA. For more information, or to download a trial version of ProteoIQ, please visit www.bioinquire.com.
Contact: James A. Atwood
Chief Operating Officer
BioInquire
Phone: 706/583-4000 or 888/291-2246
jatwood@bioinquire.com
###
Contact
Bioinquire, LLC
Ron Orlando
1-888-291-2246
www.bioinquire.com
Ron Orlando
1-888-291-2246
www.bioinquire.com
Contact
Categories